Outcome of Heart Transplant Candidates Based on a High Volume Heart Transplant Center Experience in Iran

A Amin1, N S Razavi1, A Mohamadifar1

  • 1Rajaie Cardiovascular, Medical and Research Center, Iran University of Medical Sciences,Tehran, Iran.

Insights

Predicting mortality in heart transplant candidates is crucial. Right atrial pressure, pulmonary capillary wedge pressure, cardiac index, and systolic blood pressure are key indicators for patients awaiting heart transplantation.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Health Services Research

Background:

  • The heart transplant waiting list is a critical data registry for understanding patient characteristics and outcomes.
  • Advanced heart failure necessitates careful management and prognosis assessment for patients awaiting transplantation.

Purpose of the Study:

  • To investigate the prognosis of patients on the heart transplant waiting list.
  • To identify factors associated with increased mortality risk in this population.

Main Methods:

  • Retrieved demographic, clinical, hemodynamic, and echocardiographic data from a national heart transplantation registry (2011-2018).
  • Compared patient outcomes in four groups: death before transplant, death after transplant, alive without transplant, and transplanted and alive.
  • Analyzed data from 207 patients, with idiopathic dilated cardiomyopathy being the most common etiology.

Main Results:

  • 86 patients (41%) received a heart transplant; median wait time was 84 days.
  • 54 patients (26.1%) died while waiting or post-transplant, and 32% remained alive.
  • Multivariate analysis identified elevated right atrial pressure, pulmonary capillary wedge pressure, lower cardiac index, and systolic blood pressure as independent predictors of mortality.

Conclusions:

  • The heart transplant waiting list registry provides valuable data for improving allocation strategies and administrative planning.
  • Developing accurate predictive models using identified mortality predictors can enhance care for advanced heart failure patients.
Abstract